## Gene Summary
ADAMTS1 (ADAM Metallopeptidase with Thrombospondin Type 1 Motif 1) is an enzyme that belongs to the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family, known for their roles in proteolysis and modulation of cell-matrix interactions. The gene is expressed in a variety of tissues, including reproductive tissues, heart, lung, and kidney. ADAMTS1 is involved in the cleavage of proteoglycans, the degradation of the extracellular matrix, follicular rupture, and has implications in the regulation of inflammatory responses.

## Gene Drugs, Diseases, Phenotypes, and Pathways
ADAMTS1 has been implicated in several biological pathways and physiological processes such as angiogenesis, inflammation, arthritis, and cancer progression. Its enzymatic activity influences the turnover and remodeling of the extracellular matrix, which is vital in developmental processes and disease conditions such as osteoarthritis and various cardiovascular diseases. ADAMTS1 has shown relevance in tumor progression and metastasis, particularly in conditions like breast cancer and gastric cancer, owing to its role in modifying the tumor microenvironment.

## Pharmacogenetics
Although ADAMTS1 is significantly studied in the context of its biological functions and disease associations, specific pharmacogenetic data linking ADAMTS1 directly to drug response and pharmacodynamic properties is limited. The gene's role in modulating extracellular matrix dynamics and involvement in cancer pathways might suggest potential indirect implications in the efficacy or safety of therapies targeting these pathways, such as metalloproteinase inhibitors or anti-angiogenic agents used in oncology. Nonetheless, direct associations with specific drugs based on genetic variability in ADAMTS1 require further detailed studies to establish robust pharmacogenetic relationships.